Tscan Therapeutics (TCRX) faces delisting and liquidity risk as its stock price approaches below $1

2026-10-11 23:49

Economic Observation Network The stock price of TCRX is close to below $1, with light trading volume, and there is delisting and liquidity risk.

Delisting and liquidity risk
The stock price is close to below $1, with light trading volume. Once compliance issues are triggered, the volatility will be amplified 。

The above content is based on publicly available information and does not constitute investment advice.